Pharmacokinetic Interaction Between Diltiazem and ACT-541468 in Healthy Subjects
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to investigate whether repeated administration of a
cardiac medication (diltiazem) can affect the pharmacokinetics (i.e., amount and time of
presence in the blood) of ACT-541468